If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWIN.L Regulatory News (WIN)

  • There is currently no data for WIN

Form 8.3 - Wincanton plc

11 Mar 2024 13:33

RNS Number : 3812G
Barclays PLC
11 March 2024

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

WINCANTON PLC

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

08 Mar 2024

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

10p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

2,909,716

2.34%

295,534

0.24%

(2)

Cash-settled derivatives:

and/or controlled:

269,311

0.22%

2,857,531

2.29%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

3,179,027

2.55%

3,153,065

2.53%

(b)

Rights to subscribe for new securities (including directors and other executive

options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

10p ordinary

Purchase

129,416

5.9600 GBP

10p ordinary

Purchase

7,198

5.9630 GBP

10p ordinary

Purchase

2,842

5.9602 GBP

10p ordinary

Purchase

1,763

5.9650 GBP

10p ordinary

Sale

161,894

5.9600 GBP

10p ordinary

Sale

58,019

5.9590 GBP

10p ordinary

Sale

20,438

5.9599 GBP

10p ordinary

Sale

2,587

5.9602 GBP

10p ordinary

Sale

235

5.9700 GBP

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

10p ordinary

CFD

Decreasing Short

33,773

5.9600 GBP

10p ordinary

SWAP

Increasing Long

58,019

5.9590 GBP

10p ordinary

CFD

Increasing Short

727

5.9600 GBP

10p ordinary

SWAP

Increasing Short

729

5.9637 GBP

10p ordinary

SWAP

Increasing Short

2,468

5.9636 GBP

10p ordinary

CFD

Increasing Short

7,198

5.9629 GBP

10p ordinary

SWAP

Opening Long

20,438

5.9599 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

11 Mar 2024

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETBXGDXGXBDGSB
Date   Source Headline
27th Jan 20238:43 amRNSDirector Declaration
27th Jan 20237:08 amRNSDirector Declaration
13th Jan 20237:00 amRNSQ3 TRADING UPDATE
15th Nov 20227:00 amRNSHalf Year Results
7th Oct 20227:00 amRNSTrading Update and Notice of Results
28th Jul 20227:00 amRNSAppointment of Chief Financial Officer
12th Jul 20227:00 amRNSAGM Trading Statement
7th Jul 20227:00 amRNSNotification of Capital Markets Event
30th May 202212:52 pmPRNHolding(s) in Company
23rd May 20224:43 pmPRNDirector/PDMR Shareholding
20th May 20227:00 amRNSPreliminary Results
5th May 20227:00 amRNSNew Five-Year Contract With The White Company
5th Apr 20227:00 amRNSTrading Update and Notice of Results
1st Apr 20223:25 pmPRNPurchase of Shares for the Employee Benefit Trust
24th Mar 202212:21 pmPRNWincanton publishes financial calendar dates
22nd Mar 20223:10 pmPRNDirector/PDMR Shareholding
3rd Mar 20224:26 pmPRNDirector/PDMR Shareholding
1st Mar 202211:41 amPRNDisclosure Section 430(2B) Companies Act 2006
22nd Feb 20223:09 pmPRNDirector/PDMR Shareholding
14th Feb 20229:30 amRNSAppointment of Interim CFO
20th Jan 20227:00 amRNSQ3 Trading Update
19th Jan 202212:19 pmPRNDirector/PDMR Shareholding
4th Jan 20222:53 pmPRNDirector/PDMR Shareholding
21st Dec 20214:20 pmPRNDirector/PDMR Shareholding
20th Dec 20219:00 amRNSPurchase of shares for Employee Benefit Trust
19th Nov 20213:47 pmPRNDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
17th Nov 20217:00 amRNSWincanton wins new Primark contract
16th Nov 20217:00 amRNSBoard Change
19th Oct 20213:36 pmPRNDirector/PDMR Shareholding
5th Oct 20217:00 amRNSTrading Update and Notice of Results
29th Sep 202111:26 amPRNDirector/PDMR Shareholding
17th Sep 202110:03 amPRNDirector/PDMR Shareholding
13th Sep 20217:00 amRNSAcquisition of Cygnia and Trading Update
10th Sep 20215:05 pmPRNHolding(s) in Company
20th Aug 20211:28 pmPRNDirector/PDMR Shareholding
10th Aug 202112:01 pmPRNDirector/PDMR Shareholding
4th Aug 202112:18 pmPRNDirector/PDMR Shareholding
4th Aug 202112:14 pmPRNDirector/PDMR Shareholding
3rd Aug 202110:41 amPRNDirector/PDMR Shareholding
28th Jul 202110:42 amPRNDirector/PDMR Shareholding
20th Jul 20219:48 amRNSDirector/PDMR Shareholding
7th Jul 20211:21 pmRNSResult of AGM
7th Jul 20217:00 amRNSAGM Trading Statement
2nd Jul 20212:16 pmPRNHolding(s) in Company
24th Jun 20217:00 amRNSWincanton awarded contract extension by Ikea
22nd Jun 20213:20 pmPRNDirector/PDMR Shareholding
4th Jun 20219:08 amPRNNotice of AGM
26th May 20214:25 pmPRNDirector/PDMR Shareholding
20th May 20212:14 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.